GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytokinetics Inc (STU:KK3A) » Definitions » 3-Year EPS without NRI Growth Rate

Cytokinetics (STU:KK3A) 3-Year EPS without NRI Growth Rate : -40.40% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cytokinetics 3-Year EPS without NRI Growth Rate?

Cytokinetics's EPS without NRI for the three months ended in Mar. 2024 was €-1.22.

During the past 3 years, the average EPS without NRI Growth Rate was -40.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -23.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Cytokinetics was 55.00% per year. The lowest was -84.90% per year. And the median was 9.70% per year.


Competitive Comparison of Cytokinetics's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Cytokinetics's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytokinetics's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytokinetics's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Cytokinetics's 3-Year EPS without NRI Growth Rate falls into.



Cytokinetics 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Cytokinetics  (STU:KK3A) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Cytokinetics 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Cytokinetics's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytokinetics (STU:KK3A) Business Description

Industry
Traded in Other Exchanges
Address
350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Cytokinetics (STU:KK3A) Headlines

No Headlines